-
Study aim
-
The evaluation of how virtual reality (VR) reduces pain, fear, and anxiety in pediatric oncology patients who undergo needle based medical procedure
-
Design
-
This clinical trial consists of two parallel groups, an intervention group and a control group, for which blinding procedures are not necessary, given the absence of pharmacological agents affecting their outcomes. Moreover, the study phase does not bear any significance to this investigation. A sample size of 40 patients, with an equal allocation of 20 subjects per group, was selected through randomization protocols implemented via Minitab version 17
-
Settings and conduct
-
To examine the potential impact of VR technology on reducing pain, fear, and anxiety in pediatric oncology patients. The intervention group will receive regular medical treatment along with VR, while the control group will only receive customary care. The researchers will measure pain, fear, and anxiety levels before and after treatment through various methods including patient self reporting, researcher observations, and input from parents. Standardized questionnaires such as the Wong Baker FACE and Face Legs Activity Cry and Consolability scales will be used to assess pain management, while the Child Fear Scale and Children's Anxiety Meter State questionnaires will be utilized to evaluate fear and anxiety
-
Participants/Inclusion and exclusion criteria
-
Consent obtained from both minors and their legal guardians, while also verifying their lack of visual, auditory, or speech impairments, in addition to the need for needle based medical interventions
-
Intervention groups
-
The intervention group of this investigation is slated to undergo the customary needle administered medical protocol, complemented by immersive VR material
-
Main outcome variables
-
The provision of virtual reality technology to aid in the management of pain during treatment among children with cancer